Filing Details
- Accession Number:
- 0001187154-10-000053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-10 16:57:34
- Reporting Period:
- 2010-12-08
- Filing Date:
- 2010-12-10
- Accepted Time:
- 2010-12-10 16:57:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
873364 | Cephalon Inc | CEPH | Pharmaceutical Preparations (2834) | 232484489 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1187154 | Jr Frank Baldino | 41 Moores Road Frazer PA 19355 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-12-08 | 150,000 | $51.13 | 682,582 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-12-08 | 150,000 | $64.09 | 532,582 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option | Disposition | 2010-12-08 | 1,955 | $0.00 | 1,955 | $51.13 |
Common Stock | Non-Qualified Stock Option | Disposition | 2010-12-08 | 148,045 | $0.00 | 148,045 | $51.13 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2000-12-13 | 2010-12-13 | No | 4 | M | Direct |
0 | 2000-12-13 | 2010-12-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,545 | Indirect | by Trust |
Footnotes
- This price is a weighted average sale price. The prices at which the shares actually sold ranged from $63.75 to $64.61. The reporting person has provided to the issuer, and upon request will provide to any security holder of the issuer or to the SEC staff, information regarding the number of shares sold at each price within the range.
- Options vest 25% on each anniversary of grant and are fully vested 4 years from the date of grant. Options expire ten years from date of grant.